<?xml version="1.0" encoding="UTF-8"?>
<ref id="B104">
 <label>104</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Borgio</surname>
    <given-names>JF</given-names>
   </name>
   <name>
    <surname>Alsuwat</surname>
    <given-names>HS</given-names>
   </name>
   <name>
    <surname>Al Otaibi</surname>
    <given-names>WM</given-names>
   </name>
   <name>
    <surname>Ibrahim</surname>
    <given-names>AM</given-names>
   </name>
   <name>
    <surname>Almandil</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Al Asoom</surname>
    <given-names>LI</given-names>
   </name>
  </person-group>
  <article-title>State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2</article-title>
  <source>Arch Med Sci</source>
  <year>2020</year>
  <volume>16</volume>
  <issue>3</issue>
  <fpage>508</fpage>
  <lpage>518</lpage>
  <pub-id pub-id-type="pmid">32399096</pub-id>
 </element-citation>
</ref>
